Discussing REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib

Discussing REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib

User Photo
obr

1 year
88 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of Cabozantinib. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Up Next Autoplay